Cost-effectiveness of first-line sintilimab plus chemotherapy versus chemotherapy for advanced esophageal carcinoma in China [0.03%]
替雷利珠单抗联合化疗对比单纯化疗作为晚期食管癌一线治疗的卫生经济学价值分析
Nanlong Lin,Shiting Chen,Zhiwei Zheng et al.
Nanlong Lin et al.
Background: To evaluate the cost-effectiveness of first-line sintilimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma (ESCC) from the perspective of the Chinese health service syste...
Perceptions of risk sharing agreements in South Korea from the viewpoints of key stakeholders: a convergent parallel mixed approach [0.03%]
利益相关者视角下韩国风险分担协议的认知状况——兼论混合研究方法的收敛平行模式
Tae-Jin Lee,Kyung-Bok Son
Tae-Jin Lee
Objectives: In 2013, South Korea introduced risk-sharing agreements (RSAs) as a new reimbursement mechanism to enhance access to new medicines and to manage pharmaceutical expenditures. This study evaluates RSAs in South ...
Enhancing pharmacist intervention targeting based on patient clustering with unsupervised machine learning [0.03%]
基于无监督机器学习的患者聚类以增强药师干预目标定位能力
Chi Chun Steve Tsang,Junling Wang
Chi Chun Steve Tsang
Objectives: Adherence to the American Diabetes Association (ADA) Standards of Medical Care is low. This study aimed to assist pharmacists in identifying patients for diabetes control interventions using unsupervised machi...
Ibrahim Alabbadi,Sara Al-Ajlouny,Yazan Alsoud et al.
Ibrahim Alabbadi et al.
Background: Multiple Sclerosis (MS) imposes a significant financial burden on health-care systems. This study aims to determine the cost-of-illness (COI) for MS in Jordan, a country where data on the economic impact of MS...
Pharmacovigilance and outcomes: experience from Saudi Arabia narrative review [0.03%]
药物警戒和结果：沙特阿拉伯的叙事性综述经验
Thamir M Alshammari
Thamir M Alshammari
Introduction: Pharmacovigilance (PV) plays a central role as a quality benchmark for healthcare systems in any country. Adverse drug reactions (ADRs) contribute significantly to patient hospitalization and are major contr...
Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States [0.03%]
抗凝药阿哌沙班和利伐沙班在预防房颤患者卒中事件中的依从性对其成本效益的影响研究
Anjana Mohan,Haluk Damgacioglu,Ashish A Deshmukh et al.
Anjana Mohan et al.
Objective: Despite the beneficial effects of DOACs, suboptimal adherence is widely documented, and real-world adherence is lower than in clinical trials. The objective of this study is to compare the cost-effectiveness of...
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers [0.03%]
基于价值的医疗和卫生技术评估在新兴市场国家中的合作以克服障碍
Maximillian Otte,Hans Peter Dauben,Jeonghoon Ahn et al.
Maximillian Otte et al.
Introduction: This paper summarizes the results from a forum of healthcare experts, academia representatives, and public agency officials from emerging and established market countries on Value-Based Healthcare (VBHC) and...
Cost-effectiveness of atezolizumab plus bevacizumab as first-line therapy for metastatic renal cell carcinoma [0.03%]
阿特珠单抗联合贝伐珠单抗一线治疗转移性肾细胞癌的成本效益分析
Siying Wang,Ouyang Xie,Meiyu Wu et al.
Siying Wang et al.
Objectives: Recently, the IMmotion151 trial evaluated the safety and efficacy of atezolizumab plus bevacizumab in metastatic renal cell carcinoma (mRCC) and found that this combination led to longer progression-free survi...
Budget impact and cost per responder analysis of upadacitinib for the treatment of moderate to severe atopic dermatitis from the perspective of the social security and the private sector in Argentina [0.03%]
乌帕替尼治疗中重度特应性皮炎的预算影响和每响应者成本分析——从阿根廷社会保障体系和私营部门的角度出发
Natalia Espinola,Federico Rodríguez Cairoli,Carlos Rojas-Roque et al.
Natalia Espinola et al.
Objectives: Our study assessed the budget impact and cost per responder of upadacitinib15mg and 30 mg for moderate to severe atopic dermatitis (MS-AD) treatment from social security and private health sector perspective i...
Patients' health related quality of life after massive weight loss reconstruction in the Netherlands [0.03%]
荷兰大量体重减轻后重建患者的健康相关生活质量
Guus van Uittert,Maarten Hoogbergen,Charlotte Beaudart et al.
Guus van Uittert et al.
Objectives: The present study aimed to evaluate the impact of undergoing massive weight loss reconstruction (MWR) on health-related quality of life (HR-QoL) in the Netherlands. ...